{"id":"https://openalex.org/A5110291328","orcid":"https://orcid.org/0000-0003-0554-865X","observed_orcids":["https://orcid.org/0000-0003-0554-865X"],"display_name":"Matthew Allinder","raw_author_names":["Allinder, Matthew","Matthew Allinder"],"full_name":"Matthew Allinder","works_count":16,"cited_by_count":189,"summary_stats":{"2yr_mean_citedness":4.5,"h_index":6,"i10_index":5},"ids":{"openalex":"https://openalex.org/A5110291328","orcid":"https://orcid.org/0000-0003-0554-865X","observed_orcids":["https://orcid.org/0000-0003-0554-865X"]},"affiliations":[{"institution":{"id":"https://openalex.org/I142740786","ror":"https://ror.org/01ckdn478","display_name":"University of Louisville","country_code":"US","type":"education","lineage":["https://openalex.org/I142740786"]},"years":[2015]},{"institution":{"id":"https://openalex.org/I188950975","ror":"https://ror.org/01xsqw823","display_name":"GlaxoSmithKline (United Kingdom)","country_code":"GB","type":"company","lineage":["https://openalex.org/I188950975"]},"years":[2021]},{"institution":{"id":"https://openalex.org/I4210093621","ror":"https://ror.org/00hj12c83","display_name":"Hammersmith Medicines Research","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I4210093621"]},"years":[2021]},{"institution":{"id":"https://openalex.org/I4210114143","ror":"https://ror.org/025vn3989","display_name":"GlaxoSmithKline (United States)","country_code":"US","type":"company","lineage":["https://openalex.org/I188950975","https://openalex.org/I4210114143"]},"years":[2024,2022,2021,2020,2019,2018,2017]},{"institution":{"id":"https://openalex.org/I4210124468","ror":"https://ror.org/02vkbzw76","display_name":"PAREXEL International (United States)","country_code":"US","type":"company","lineage":["https://openalex.org/I4210124468"]},"years":[2021]},{"institution":{"id":"https://openalex.org/I4210144466","ror":"https://ror.org/04090g527","display_name":"ImmunityBio (United States)","country_code":"US","type":"company","lineage":["https://openalex.org/I4210144466"]},"years":[2026]},{"institution":{"id":"https://openalex.org/I4210166171","ror":"https://ror.org/059vag305","display_name":"Covance (United Kingdom)","country_code":"GB","type":"company","lineage":["https://openalex.org/I4210166171","https://openalex.org/I60638368"]},"years":[2021]}],"last_known_institutions":[{"id":"https://openalex.org/I4210144466","ror":"https://ror.org/04090g527","display_name":"ImmunityBio (United States)","country_code":"US","type":"company","lineage":["https://openalex.org/I4210144466"]}],"topics":[{"id":"https://openalex.org/T10143","display_name":"Chronic Obstructive Pulmonary Disease (COPD) Research","count":11,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10051","display_name":"Asthma and respiratory diseases","count":7,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10570","display_name":"Drug Transport and Resistance Mechanisms","count":3,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10665","display_name":"Cystic Fibrosis Research Advances","count":3,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10837","display_name":"Dermatology and Skin Diseases","count":2,"subfield":{"id":"https://openalex.org/subfields/2708","display_name":"Dermatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"topic_share":[{"id":"https://openalex.org/T10143","display_name":"Chronic Obstructive Pulmonary Disease (COPD) Research","value":2.35e-05,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T13657","display_name":"Aortic Thrombus and Embolism","value":1.89e-05,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11834","display_name":"Liver Diseases and Immunity","value":1.77e-05,"subfield":{"id":"https://openalex.org/subfields/2721","display_name":"Hepatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10665","display_name":"Cystic Fibrosis Research Advances","value":1.72e-05,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10570","display_name":"Drug Transport and Resistance Mechanisms","value":1.16e-05,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"x_concepts":[{"id":"71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","score":0.9661660194396973},{"id":"2776780178","wikidata":"https://www.wikidata.org/wiki/Q199804","display_name":"COPD","score":0.8855055570602417},{"id":"2992779976","wikidata":"https://www.wikidata.org/wiki/Q3286546","display_name":"Pulmonary disease","score":0.8537087440490723},{"id":"126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","score":0.6847000122070312},{"id":"1862650","wikidata":"https://www.wikidata.org/wiki/Q186005","display_name":"Physical therapy","score":0.6651157736778259}],"counts_by_year":[{"year":2015,"works_count":1,"oa_works_count":0,"cited_by_count":0},{"year":2016,"works_count":1,"oa_works_count":0,"cited_by_count":0},{"year":2017,"works_count":1,"oa_works_count":0,"cited_by_count":0},{"year":2018,"works_count":2,"oa_works_count":1,"cited_by_count":1},{"year":2019,"works_count":5,"oa_works_count":1,"cited_by_count":4},{"year":2020,"works_count":1,"oa_works_count":1,"cited_by_count":11},{"year":2021,"works_count":1,"oa_works_count":1,"cited_by_count":10},{"year":2022,"works_count":1,"oa_works_count":1,"cited_by_count":12},{"year":2023,"works_count":1,"oa_works_count":1,"cited_by_count":29},{"year":2024,"works_count":1,"oa_works_count":1,"cited_by_count":39},{"year":2025,"works_count":0,"oa_works_count":0,"cited_by_count":40},{"year":2026,"works_count":1,"oa_works_count":0,"cited_by_count":43}],"display_name_alternatives":["Allinder, Matthew","Matthew Allinder"],"block_key":"m allinder","works_api_url":"https://api.openalex.org/works?filter=author.id:A5110291328","awards_count":0,"awards_api_url":"https://api.openalex.org/awards?filter=investigators.author.id:A5110291328","updated_date":"2026-11-12T13:17:38","created_date":"2016-06-24T00:00:00"}